"Do not ever involve me," the 26-year-old 'Juno' singer responded to the official White House post Ilana Kaplan is a Staff Editor at PEOPLE. She has been working at PEOPLE since 2023. Her work has ...

EDEN PRAIRIE, Minn. — Starkey - based in Eden Prairie - introduced generative AI to its collection of hearing aids with the launch of the Omega AI in October. “This is an arms race to try to take ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

Discover the crochet trend taking the internet by storm! 🤯 In this full step-by-step tutorial, I’ll show you exactly how I made this stunning Thalpose faster than you can imagine — from start to ...

MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced it was awarded a $1.7 million Small Business ...

AI firms are now working with weapons makers and the military. Safety expert Heidy Khlaaf breaks down what that means. AI firms are now working with weapons makers and the military. Safety expert ...

We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...

LIVONIA, Mich. — It might look like something you'd see in a James Bond movie (or perhaps one of the gadgets with which Mater is equipped in Cars 2), but "the Grappler" is real, and it's in Michigan.

Microsoft is betting big on AI. Starting with integrating Bing with ChatGPT, it has implemented AI capabilities in its products. Microsoft Designer is a new product from Microsoft with AI capabilities ...

Mike Tyson is being sued by Ty Fyffe for using the Hip-Hop track “Murdergram” without permission in a viral Instagram video. In a federal lawsuit, Fyffe claims Tyson used the 1998 song “Murdergram” ...

Amicus Therapeutics (FOLD) is a very interesting biotech because it is continuing to build momentum with respect to the commercialization of both of its approved drug candidates, POMBILITI and OPFOLDA ...